Cell and Gene Outsourcing
-
Comprehensive Media Solutions For Your Protein-Based Therapies
4/8/2024
Explore a comprehensive offering of CHO cell culture media and companion feeds as well as advanced cell line development and supporting media services that enhances clone selection and titer production.
-
Strategic Management Of The Mature Product Portfolio
4/7/2024
Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.
-
Converting iPSC To T Cells: Key Challenges And Considerations
3/27/2024
Explore how by addressing challenges in differentiation, clone selection, and manufacturing, iPSC-based T cell therapies could revolutionize cancer treatment and other diseases.
-
Gain Support For Your Regulatory Submission Process
3/27/2024
Join us in this video as we delve into invaluable tips, cutting-edge tools, and unwavering support that Cytiva offers to facilitate your documentation progress.
-
An Inside Look At Cell Therapy Services And Support
3/25/2024
“Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.
-
De-Risking Drug Development With Organ-On-A-Chip Contract Research Services
3/25/2024
Delve into Emulate's variety of Organ-on-a-Chip services and tailored study design, supported by data-driven case studies showcasing its collaboration's impact on pharmaceutical decision-making.
-
Get To Know WuXi Advanced Therapies Testing Services
3/21/2024
Learn how we can help you move your pipeline forward, whether you manufacture with us at WuXi Advanced Therapies, in-house, or with one of our fellow CDMOs.
-
A Platform For Stable LVV Production Cell Lines Yield
3/21/2024
LVV manufacturing processes remain a significant hurdle for sponsors. Review the potential of a platform of packaging and producing cell lines designed to enhance LVV manufacturing efficiency.
-
Testing At WuXi Advanced Therapies
3/21/2024
Learn how a partner offering a comprehensive suite of integrated testing services designed to navigate the complexities of cell and gene therapies is critical for accelerating development timelines.
-
Overcoming Challenges In AAV And LV Viral Vector Manufacturing
3/21/2024
Mathias Kahl, Director of Process Development, shares insights on overcoming challenges in AAV and LV viral vector manufacturing.